Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Additional provision for US RMBS investigations

26 Jan 2017 07:00

RNS Number : 1779V
Royal Bank of Scotland Group PLC
26 January 2017
 

The Royal Bank of Scotland Group plc

Additional provision for US RMBS investigations and litigation

 

26 January 2017

 

 

The Royal Bank of Scotland Group plc (together with its subsidiaries, "RBS") will announce its Full Year 2016 results on 24 February 2017. Subject to any increase being required by intervening developments, the Q4 2016 results will reflect the taking of a further £3.1bn ($3.8bn) provision in relation to various investigations and litigation matters relating to RBS's issuance and underwriting of US residential mortgage-backed securities ("RMBS"). This takes the total aggregate of such provisions to £6.7bn ($8.3bn) as at 31 December 2016. This further provision would have reduced RBS's Tangible Net Asset Value ("TNAV") per share at 30 September 2016 by 27p to 311p and RBS's Q3 2016 CET1 capital ratio by 135bps to 13.6%. This provision does not directly impact the distributable reserves of The Royal Bank of Scotland Group plc.

 

RBS continues to cooperate with the US Department of Justice ("DOJ") in its civil and criminal investigations of RMBS matters, and RBS considers it appropriate to take this provision now in relation to those investigations as well as other RMBS litigation matters. The duration and outcome of these investigations and other RMBS litigation matters remain uncertain, including in respect of whether settlements for all or any of such matters may be reached.

 

RBS emphasises that further substantial additional provisions and costs may be recognised and, depending on the final outcome, other adverse consequences may occur (see RBS's existing market disclosures). The existing disclosures also provide further details of the US RMBS-related investigations by the DOJ and other agencies and bodies, including several state attorneys general, and various litigation matters.

 

Ross McEwan, RBS's Chief Executive Officer, said:

 

"Putting our legacy litigation issues behind us, including those relating to RMBS, remains a key part of our strategy. It is our priority to seek the best outcome for our shareholders, customers and employees."

 

Ross McEwan (Chief Executive Officer) and Ewen Stevenson (Chief Financial Officer) will host a conference call for investors and analysts at 8.00am UK time today. A replay of the call will be made available shortly afterwards. Only items relating to the above announcement will be discussed on the call; there will be no references and discussion relating to other matters and the Full Year 2016 results. Dial-in details for the call can be found below.

 

Dial-in details:

UK: 0800 694 8082

International: +44 (0) 1452 568 172

US: +1 866 966 8024

Conference ID: 60246489

 

Replay details:

UK FreeCall: 0800 953 1533

Std International: +44 (0)1452 550 000

USA FreeCall: +1 (866) 247 4222

Conference ID: 60246489

 

 

For further information, please contact:

 

Investor Relations

Alexander Holcroft

Head of Equity Investor Relations

+44 (0) 20 7672 1758

 

Matthew Richardson

Head of Fixed Income Investor Relations

+44 (0) 20 7678 1800

 

RBS Media Relations

+44 (0) 131 523 4205

 

Forward Looking Statements

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those related to RBS and its subsidiaries' regulatory capital position, risk-weighted assets, impairment losses and credit exposures under certain specified scenarios. In addition, forward-looking statements may include, without limitation, statements typically containing words such as "intends", "expects", "anticipates", "targets", "plans", "estimates" and words of similar import. These statements concern or may affect future matters, such as RBS's future economic results, business and capital plans and current strategies. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, fiscal and regulatory developments, competitive conditions, technological developments, exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBS's actual results are discussed in RBS's UK Annual Report and materials filed with, or furnished to, the US Securities and Exchange Commission, including, but not limited to, RBS's Reports on Form 6-K and most recent Annual Report on Form 20-F. The forward-looking statements contained in this announcement speak only as of the date of this announcement and RBS does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

Legal Entity Identifier: 2138005O9XJIJN4JPN90

 

ENDS

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCQQLBLDFFZBBX
Date   Source Headline
20th Sep 20197:00 amRNSAppointment of CEO
12th Sep 20192:29 pmRNSForm 8.3 - Accesso Technology Group plc
9th Sep 20198:30 amRNSBarclays Global Financial Services Conference
5th Sep 20192:10 pmRNSPublication of Suppl.Prospcts
4th Sep 20197:00 amRNSUpdate on Charges Related to PPI
3rd Sep 201912:49 pmRNSForm 8.3 - Accesso Technology Group plc
30th Aug 20193:03 pmRNSTotal Voting Rights
29th Aug 20195:16 pmRNSDirector/PDMR Shareholding
29th Aug 20193:13 pmRNSDividend Declaration
14th Aug 20192:53 pmRNSDirector/PDMR Shareholding
12th Aug 20192:58 pmRNSForm 8.3 - Accesso Technology Group plc
5th Aug 20197:15 amRNSDirector Declaration
5th Aug 20197:00 amRNSAppointment of Non-Executive Director
2nd Aug 20192:43 pmRNSPublication of a Prospectus
2nd Aug 20197:31 amRNSNatWest Markets N.V. Interim Results 2019
2nd Aug 20197:00 amRNSInterim Results 2019 - Part 2 of 2
2nd Aug 20197:00 amRNSInterim Results 2019 - Part 1 of 2
31st Jul 20195:41 pmRNSDirector/PDMR Shareholding
31st Jul 201912:43 pmRNSTotal Voting Rights
25th Jul 20193:07 pmRNSForm 8.3 - Accesso Technology Group PLC
19th Jul 20197:00 amRNSRoss McEwan announced CEO National Australia Bank
16th Jul 201910:22 amRNSDirector Declaration
3rd Jul 20191:58 pmRNSForm 8 (DD) - Premier Technical Services Group plc
1st Jul 20191:54 pmRNSDirector/PDMR Shareholding
28th Jun 20192:45 pmRNSDividend Declaration
28th Jun 20191:19 pmRNSTotal Voting Rights
24th Jun 20198:00 amRNSRBS Investor Seminar : Technology & Innovation
20th Jun 20192:33 pmRNSTakeover Panel PremierTechnical Services Group plc
18th Jun 20195:09 pmRNSPublication of Suppl.Prospcts
17th Jun 20197:00 amRNSImpact of Alawwal bank / Saudi British Bank merger
11th Jun 20193:02 pmRNSDirector/PDMR Shareholding
3rd Jun 20193:33 pmRNSConfirmation re stated post-offer intentions
31st May 20195:06 pmRNSDividend Declaration
31st May 20193:04 pmRNSTotal Voting Rights
31st May 201912:39 pmRNSDirector/PDMR Shareholding
20th May 20196:04 pmRNSForm 8.3 - WYG PLC
20th May 201910:37 amRNSPublication of Suppl.Prospcts
16th May 20194:11 pmRNSRBS Group welcomes credit ratings action by S&P
16th May 201911:40 amRNSAcknowledgment of two settlements on FX trading
10th May 20193:12 pmRNSDirector/PDMR Shareholding
3rd May 201912:10 pmRNSRBSG pricing of US$1.25bn of Senior Notes
2nd May 201910:25 amRNSDirector/PDMR Shareholding
30th Apr 20193:24 pmRNSTotal Voting Rights
29th Apr 201911:07 amRNSPublication of Suppl.Prospcts
26th Apr 20197:00 amRNSQ1 Interim Management Statement
25th Apr 20196:03 pmRNSResult of AGM
25th Apr 20192:00 pmRNSAGM Statement
25th Apr 20197:00 amRNSDirectorate Change
24th Apr 20193:03 pmRNSDividend Declaration
23rd Apr 201912:46 pmRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.